Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Bio Medica Laboratories Annual General Meeting

Bio Medica Laboratories Ltd announced the outcome of its 11th Annual General Meeting, where shareholders approved financial statements, director re-appointment, auditor appointment, and FII investment limits.

Source

NSE filing, NSE: BMLL. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bio Medica Laboratories Ltd: key numbers

Share price
₹154.90
Market cap
₹194.8 Cr
Revenue (annual)
₹43.09 Cr
Net profit (annual)
₹11.89 Cr
P/E (TTM)
16.4×Sector 46.1×
Promoter holding
67.70%
FII holding
4.78%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bio Medica Laboratories Ltd

All →

Other annual general meeting announcements

All →